VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.
VaxEquity has raised $870K in total funding. The most recent round was Grant. The last funding was announced in June 2023.
VaxEquity's investors include Innovate UK, Morningside Venture Partners.
VaxEquity is headquartered in Cambridge, United States.
VaxEquity is a biotechnology company that develops RNA therapeutics and vaccines.
VaxEquity is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"VaxEquity — Funding & Investors." VCBacked, June 5, 2023, https://www.vcbacked.co/company/vaxequity. Accessed September 30, 2026.
VCBacked. (2023). VaxEquity — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/vaxequity
{{cite web |title=VaxEquity — Funding & Investors |url=https://www.vcbacked.co/company/vaxequity |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated